Format

Send to

Choose Destination
Curr Opin Mol Ther. 2005 Jun;7(3):202-8.

Smoking cessation treatment: pharmacogenetic assessment.

Author information

1
University of Bristol, Department of Experimental Psychology Bristol, UK. marcus.munafo@bristol.ac.uk

Abstract

This review focuses on the current status and future directions of pharmacogenetics research into responses to treatments for nicotine dependence and smoking cessation. Research remains in its infancy and, although the potential for individualized treatment tailored to genotype is promising, there are practical, ethical and social considerations that must be addressed before such research is translated into clinical practice. In particular, future studies that need to be conducted before such research is translated into clinical practice and potential limitations and barriers to this translation are described.

PMID:
15977416
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center